District Ii Alcohol And Drug Program | |
119 S Kendrick Ave Glendive MT 59330-1626 | |
(406) 377-5942 | |
(406) 377-3050 |
Full Name | District Ii Alcohol And Drug Program |
---|---|
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | 119 S Kendrick Ave, Glendive, Montana |
Authorized Official Name and Position | Jerry D Schlepp (EXECUTIVE DIRECTOR) |
Authorized Official Contact | 4063775942 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
District Ii Alcohol And Drug Program 119 S Kendrick Ave Glendive MT 59330-1626 Ph: (406) 377-5942 | District Ii Alcohol And Drug Program 119 S Kendrick Ave Glendive MT 59330-1626 Ph: (406) 377-5942 |
NPI Number | 1144366246 |
---|---|
Provider Enumeration Date | 01/29/2007 |
Last Update Date | 02/19/2008 |
Identifier | Type | State | Issuer |
---|---|---|---|
1144366246 | NPI | - | NPPES |
320042 | Medicaid | MT | |
76361 | Other | MT | BCBS PROVIDEER NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | 211-07 (Montana) | Primary |
News Archive
A new survey of medical schools in the United States shows that the number of full time faculty members has increased, the number of enrolled students has remained steady, and approximately half of applicants and entering students are women.
A study by the University of Exeter and the Peninsula Medical School for the first time links thyroid disease with human exposure to perfluorooctanoic acid (PFOA). PFOA is a persistent organic chemical used in industrial and consumer goods including nonstick cookware and stain- and water-resistant coatings for carpets and fabrics.
For the first time, researchers have employed a gene-editing technique involving low-dose irradiation to repair patient cells, according to a study published in the journal Stem Cells Translational Medicine. This method, developed by researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute, is 10 times more effective than techniques currently in use.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
Patients diagnosed with breast cancer or depression who are seeking a medical expert in their own community to guide them through treatment now have a place to start. Qforma, an advanced analytics and predictive modeling company, today introduced the new phase of its first-of-its-kind healthcare database "Most Influential Doctors," or MID, presented by USA TODAY.
› Verified 6 days ago
Hope Counseling And Consulting Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 N Kendrick Ave Ste 201, Glendive, MT 59330 Phone: 406-377-3370 Fax: 406-377-3333 | |
Eastern Montana Community Mental Health Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 N Kendrick Ave, Glendive, MT 59330 Phone: 406-377-6075 | |
Hope Counseling & Consulting Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 N Kendrick Ave Ste 201, Glendive, MT 59330 Phone: 406-377-3370 Fax: 406-377-3333 | |
Center Mind Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 1/2 S Merrill Ave Ste 8, Glendive, MT 59330 Phone: 608-669-5050 | |
Hope Counsleing & Consulting Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 N Kendrick Ave Ste 201, Glendive, MT 59330 Phone: 406-377-3370 Fax: 406-377-3333 | |
Glendive Counseling Center Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 115 W Valentine St, Suite 2, Glendive, MT 59330 Phone: 406-377-6217 |